American Association for the Advancement of Science, Science Translational Medicine, 157(4), 2012
DOI: 10.1126/scitranslmed.3004595
American Association for the Advancement of Science, Science Translational Medicine, 157(4), 2012
DOI: 10.1126/scitranslmed.3004403
Full text: Unavailable
In a case study, the authors report an increase in phosphorylated neurofilament heavy chain, a marker of neuroaxonal damage, in the plasma of a blast-exposed patient immediately after injury. They suggest that this phosphoprotein may be a useful body fluid indicator of acute blast traumatic brain injury.